Search hospitals > Oklahoma > Oklahoma City
Stephenson Cancer Center
Claim this profileOklahoma City, Oklahoma 73104
Global Leader in Cancer
Global Leader in Solid Tumors
Conducts research for Ovarian Cancer
Conducts research for Parotid Gland Cancer
Conducts research for Breast Cancer
295 reported clinical trials
31 medical researchers
Summary
Stephenson Cancer Center is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Cancer, Solid Tumors, Ovarian Cancer, Parotid Gland Cancer, Breast Cancer and other specialties. Stephenson Cancer Center is involved with conducting 295 clinical trials across 276 conditions. There are 31 research doctors associated with this hospital, such as Rene Y. McNall-Knapp, Debra L. Richardson, Kathleen Moore, M.D., MS, and Raid Aljumaily.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Solid Tumors
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Rene Y. McNall-KnappUniversity of Oklahoma Health Sciences Center8 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
72 reported clinical trials
127 drugs studied
Debra L. RichardsonUniversity of Oklahoma Health Sciences Center2 years of reported clinical research
Expert in Ovarian Cancer
Studies Parotid Gland Cancer
33 reported clinical trials
52 drugs studied
Kathleen Moore, M.D., MSUniversity of Oklahoma Health Sciences Center1 year of reported clinical research
Expert in Ovarian Cancer
Expert in Cancer
32 reported clinical trials
83 drugs studied
Raid AljumailyUniversity of Oklahoma Health Sciences Center8 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
26 reported clinical trials
44 drugs studied
Clinical Trials running at Stephenson Cancer Center
Ovarian Cancer
Endometrial Cancer
Breast Cancer
Solid Tumors
Cervical Cancer
Cancer
Acute Myeloid Leukemia
Pancreatic Cancer
Lymphoma
Lung Cancer
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Avutometinib + Defactinib
for Ovarian and Cervical Cancer
The purpose of this research is to test the effectiveness and safety of the study drugs (VS-6766 and defactinib), and see what effects (good and bad) these drugs have on the patients with endometrioid cancer, mucinous ovarian cancer, high-grade serous ovarian cancer, or solid gynecological cancer.
Recruiting1 award Phase 210 criteria
CUSP06
for Ovarian Cancer
This phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors.
Recruiting1 award Phase 110 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Stephenson Cancer Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.